ANGLE PLC
Offers a liquid biopsy system to harvest circulating tumor cells for oncology diagnostics & research.
AGL | IL
Overview
Corporate Details
- ISIN(s):
- GB0034330679 (+3 more)
- LEI:
- 213800BY11K6W3NMS374
- Country:
- United Kingdom
- Address:
- GROUND FLOOR, 10 NUGENT ROAD, GU2 7AF GUILDFORD
- Website:
- https://angleplc.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
ANGLE plc is a medical diagnostics company specializing in liquid biopsy solutions for oncology. The company's core technology is the proprietary and patented Parsortix® system, which uses microfluidics to capture and harvest intact circulating tumor cells (CTCs) and CTC clusters from blood for downstream molecular analysis. ANGLE markets the FDA-cleared Parsortix PC1 instrument for use in clinical laboratories. Additionally, the company provides comprehensive, GCP-compliant laboratory services for biopharmaceutical and translational research clients, supporting projects in drug development and clinical studies. ANGLE's non-invasive technology enables detailed cancer analysis, aiming to improve diagnostics and patient care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-02 12:25 |
Additional Subscription
|
English | 19.1 KB | ||
| 2025-12-01 18:55 |
Result of Retail Offer
|
English | 19.5 KB | ||
| 2025-11-25 18:50 |
Update to Admission of Fundraising Shares
|
English | 9.9 KB | ||
| 2025-11-25 09:35 |
Launch of Retail Offer
|
English | 42.0 KB | ||
| 2025-11-25 09:35 |
Result of Oversubscribed Placing and Subscription
|
English | 15.0 KB | ||
| 2025-11-24 19:45 |
Proposed Placing and Subscription
|
English | 180.9 KB | ||
| 2025-11-18 08:20 |
QIAGEN Collaboration and Co-Marketing Agreement
|
English | 16.7 KB | ||
| 2025-11-05 19:30 |
Further Update on Funding
|
English | 10.6 KB | ||
| 2025-11-05 08:25 |
CelLBxHealth Presents Proof-of-Concept Study
|
English | 16.9 KB | ||
| 2025-11-04 08:25 |
Expert Consensus on CTCs; Update on Funding
|
English | 17.7 KB | ||
| 2025-10-29 08:00 |
CHANGE OF NAME
|
English | 11.9 KB | ||
| 2025-10-16 08:00 |
Appointments: Interim CEO and senior board advisor
|
English | 14.9 KB | ||
| 2025-09-29 08:00 |
Presentation of Data on Glioblastoma
|
English | 19.5 KB | ||
| 2025-09-09 08:01 |
Interim Results
|
English | 255.8 KB | ||
| 2025-09-09 08:00 |
Change of Adviser
|
English | 12.5 KB |
Automate Your Workflow. Get a real-time feed of all ANGLE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANGLE PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANGLE PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
